I am a translational cancer scientist working on targeted therapy of prostate cancer. My work primarily focusses on the identification of molecular/cellular mechanisms that lead to the development of castrate resistant prostate cancer (CRPC). In particular I am developing therapeutic strategies to inhibit the oncogenic transcription factor the Androgen Receptor (AR) which is the major driver of the disease with an overall goal to eradicate CRPC or delay its onset.
Lecturer in Molecular Cancer Biology